LAFFI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.749
EU - Europa 10.144
AS - Asia 1.933
AF - Africa 87
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 27.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.705
RU - Federazione Russa 3.452
PL - Polonia 1.996
SE - Svezia 1.187
IE - Irlanda 1.133
IT - Italia 762
SG - Singapore 600
UA - Ucraina 540
HK - Hong Kong 533
DE - Germania 416
CN - Cina 407
FI - Finlandia 269
GB - Regno Unito 170
IN - India 134
JO - Giordania 98
CH - Svizzera 85
TR - Turchia 78
CI - Costa d'Avorio 59
VN - Vietnam 48
FR - Francia 43
CA - Canada 40
BE - Belgio 38
NL - Olanda 21
JP - Giappone 18
SC - Seychelles 18
KR - Corea 10
EG - Egitto 7
ES - Italia 6
BG - Bulgaria 5
AT - Austria 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MX - Messico 4
AL - Albania 3
BR - Brasile 3
AU - Australia 2
EU - Europa 2
ID - Indonesia 2
IR - Iran 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
LU - Lussemburgo 1
NO - Norvegia 1
NP - Nepal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 27.921
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.038
Warsaw 1.994
Fairfield 1.881
Chandler 1.190
Dublin 1.133
Ashburn 913
Jacksonville 887
Woodbridge 838
Cambridge 776
Seattle 763
Wilmington 640
Houston 638
Singapore 479
Ann Arbor 369
Hong Kong 296
Princeton 287
Boardman 216
Boston 216
Lawrence 207
Altamura 202
Buffalo 186
Beijing 178
Mumbai 112
Medford 111
Florence 108
San Diego 105
Bern 85
Shanghai 85
Moscow 72
Bremen 69
Izmir 66
Abidjan 59
Norwalk 56
New York 51
Milan 44
Los Angeles 38
Dong Ket 32
Hillsboro 32
Andover 30
Brussels 30
Kent 29
Toronto 29
Falls Church 28
Auburn Hills 26
Verona 23
Yubileyny 22
London 21
Salerno 20
Dearborn 19
Rome 18
Frankfurt Am Main 17
Washington 17
Osaka 16
Bari 15
Phoenix 15
Guangzhou 14
West Jordan 12
Laurel 11
Old Bridge 9
Redmond 9
Naples 8
Pune 8
Helsinki 7
Munich 7
Tappahannock 7
Antwerp 6
Barcelona 6
Chengdu 6
Grosseto 6
Kunming 5
Mandello del Lario 5
Nanjing 5
Seoul 5
Avigliano 4
Brno 4
Frankfurt am Main 4
Incisa 4
Las Vegas 4
Padova 4
Partinico 4
Saint Petersburg 4
San Mateo 4
Seregno 4
Vienna 4
Aachen 3
Caserta 3
Ferriere 3
Hanover 3
Lariano 3
Leawood 3
Legnano 3
Montalbano Jonico 3
Montréal 3
Naaldwijk 3
Ottawa 3
Redwood City 3
Riardo 3
Sofia 3
Ahmedabad 2
Amsterdam 2
Totale 19.053
Salva come PNG Salva come JPEG
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 269
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 255
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 253
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 252
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 250
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 244
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 239
Complete resolution of primary sclerosing peritonitis ("abdominalCocoon") following long term therapy for tropheryma whipplei: a case report and review of literature. 238
Acute on chronic liver failure: From pathophysiology to clinical management. 229
Neuroendocrine dysregulation in irritable bowel syndrome patients: A pilot study 229
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 228
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. 219
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 210
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma 208
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 200
Macro-aspartate aminotransferase in a healthy woman 197
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 194
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma. 175
Acute viral hepatitis increases liver stiffness values measured by transient elastography 156
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 152
Host genetic determinants in HCV-related mixed cryoglobulinemia 147
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 146
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 142
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 141
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 141
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 138
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 138
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 137
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 136
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 135
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 134
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 134
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 133
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 133
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 131
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 131
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. 130
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 129
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 128
Host genetic determinants in HCV-related mixed cryoglobulinemia 128
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 127
DRESS syndrome in a patient with chronic hepatic encephalopathy. 127
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 126
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 126
ADMA correlates with portal pressure in patients with compensated cirrhosis. 125
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 123
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 123
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 123
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 123
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 123
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 120
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 120
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 120
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 119
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 119
Adiponectin and the cardiovascular system: from risk to disease. 119
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 119
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 117
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 117
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 117
Screening of distress among hospitalized patients in a department of internal medicine. 116
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 115
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 115
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 115
T(14;18) translocation in chronic hepatitis C virus infection 114
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 114
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 114
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 114
Torasemide in the treatment of patients with cirrhosis and ascites. 113
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 113
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 112
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 112
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 112
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 111
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 111
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 111
Functional renal alterations in chronic liver diseases. 111
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 110
Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry 110
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 109
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 109
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 109
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 109
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 109
Loop diuretic therapy in liver cirrhosis with ascites 108
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 108
Analysis of HCV persistence in patients with sustained virological response 108
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 108
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 108
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 107
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 107
Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib 107
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 107
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 106
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 106
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 105
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 105
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 105
Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health. 105
Host genetic determinants in HCV-related mixed cryoglobulinemia 105
Totale 13.935
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.241 0 0 0 0 461 544 471 581 425 294 379 86
2020/20212.964 246 185 274 311 109 391 91 276 224 446 173 238
2021/20221.845 45 190 92 79 69 71 76 111 92 63 402 555
2022/20235.035 466 677 269 386 451 938 673 312 569 24 146 124
2023/20241.593 68 209 306 91 102 231 45 357 22 45 56 61
2024/20258.143 411 1.269 829 1.929 3.705 0 0 0 0 0 0 0
Totale 28.007